---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-22-003841"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:28:28.572152+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ReWalk Q3 revenue down 63% to $0.9M, loss widens; submits first Medicare case for coverage

## Summary
- Q3 revenue $0.9M, down 63% YoY from $2.0M; net loss widened to $5.5M from $2.7M.
- Gross margin fell to 25% from 58% due to lower personal device sales and higher costs.
- Submitted first Medicare case to MAC for exoskeleton coverage; German court hearing Nov 10.
- Cash $74.0M, no debt; $0.9M in share repurchases since program initiation.

## SEC filing metadata
- accession: 0001178913-22-003841
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891322003841/0001178913-22-003841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891322003841/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-22-003841
- JSON: https://secwatch.observer/filing/0001178913-22-003841.json
- Plain text: https://secwatch.observer/filing/0001178913-22-003841.txt

## Key facts
- Earnings Releases
  Lifeward Ltd. reported the third quarter ended September 30, 2022 results: revenue $0.9 million, net income $5.5 million dollars.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $0.9 million
  - Net income: $5.5 million dollars
  - Result: reported results
  source text: to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries As of November 4 th , ReWalk Has Repurchased $0.9 Million of Common Stock Since Initiation of Its Program German Federal Social Court Hearing on November 10 th with Ruling Expected Shortly After MARLBOROUGH, Mass. BERLIN, Germany and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1607962/000117891322003841/0001178913-22-003841-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.